Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

615.00p
   
  • Change Today:
      19.00p
  • 52 Week High: 630.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 120.21m
  • Volume: 225,031
  • Market Cap: £739.27m
  • RiskGrade: 125
  • Beta: 0.00

Oxford Biomedica signs new Covid vaccine deal with AstraZeneca

By Frank Prenesti

Date: Friday 01 Jul 2022

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica has signed a new three-year deal to make AstraZeneca's Covid-19 vaccine beyond this year when the original agreement expires, the company said on Friday.
The Oxford-based gene and cell therapy group said it expected to record about £30m in revenue from the contract in the current financial year.

Under the new deal, manufacturing of vaccines at Oxford manufacturing facility, Oxbox, will be available to AstraZeneca on an as-needed basis beyond 2022.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 615.00p
Change Today 19.00p
% Change 3.19 %
52 Week High 630.00p
52 Week Low 232.50p
Volume 225,031
Shares Issued 120.21m
Market Cap £739.27m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 03-Oct-2025

Time Volume / Share Price
16:47 3,678 @ 613.10p
16:35 4 @ 615.00p
16:35 1,026 @ 615.00p
16:35 55,961 @ 615.00p
16:35 276 @ 615.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page